News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
2024 Lunch and Learn Series: Initial Steps for Navigating a Rare Cancer Diagnosis – TargetCancer Foundation
Photo from TargetCancer Foundation/LinkedIn
Sep 7, 2024, 10:25

2024 Lunch and Learn Series: Initial Steps for Navigating a Rare Cancer Diagnosis – TargetCancer Foundation

TargetCancer Foundation shared a post on LinkedIn:

“Rare Cancer Day is only a few weeks away! Join us on September 30 for the next webinar in our 2024 Lunch and Learn Series: ‘Patients and Providers as Partners: Initial Steps for Navigating a Rare Cancer Diagnosis’.

In this webinar, Jacob J. Adashek, DO and patient advocate Dana Deighton will discuss the unique challenges faced by rare cancer patients and the initial steps that patients and providers can take to build a partnership to navigate these challenges.

Register and submit your questions now!”

Source: TargetCancer Foundation/LinkedIn

cancer Dana Deighton Jacob Adashek Lunch and Learn Series 2024 OncoDaily Oncology rare cancer Rare Cancer Day TargetCancer Foundation
Special Coverage
Blog
Nov 13, 2024, 11:25
Some information you should know about lung cancer - American Cancer Society
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center
Blog
Nov 13, 2024, 10:16
Highlights from IU Simon Comprehensive Cancer Center’s End Lung Cancer Now Gathering - Hoosier Cancer Research Network
Blog
Nov 13, 2024, 10:06
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system